早期干预可以预防瘤性结肠炎的疾病进展 - 一个多中心的回顾性研究.
Joana Camões Neves1, Tiago Leal1, Samuel Fernandes2
1Gastroenterology Department, Unidade Local de Saúde Braga, Braga, Portugal.
概括
对于性结肠炎 (UC) 的早期生物疗法 (BT) 可以防止长期的疾病进展. 这项研究表明,在诊断后12个月内启动BT可以改善结果并减少结构损伤.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 性结肠炎 (UC) 越来越被认为是一种渐进的疾病.
- 与克罗恩病不同,UC的早期生物疗法 (BT) 益处尚未得到充分证实.
- 在UC中疾病进展需要进一步评估以指导治疗策略.
研究的目的:
- 评估早期干预对性结肠炎 (UC) 结果的影响.
- 为了确定早期的生物疗法 (BT) 启动是否可以预防疾病的进展.
- 评估早期BT对UC结构和临床终点的长期影响.
主要方法:
- 成年UC患者的回顾性多中心研究,随访时间≥5年.
- 早期干预定义为在诊断后≤12个月内启动BT.
- 主要结局:UC进展 (近端延伸,结构变化,发育不良/癌症). 二次结局:住院治疗,手术,使用皮质类固醇.
主要成果:
- 晚期BT开始独立预测复合UC进展 (HR4.39,p=0.005).
- 早期BT减少了近位疾病扩展 (28.6%与0.0%,p=0.001).
- 晚期BT预测结肠结构损伤 (HR 4.83,p=0.033);没有观察到临床结果差异.
结论:
- 早期启动生物治疗 (BT) 可以减轻性结肠炎 (UC) 的长期疾病进展.
- 对于UC管理的早期干预,存在一个关键的机会窗口.
- 调查结果支持考虑早期的BT来改变UC的渐进过程.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
780
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
780
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
976
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
976
Drugs for Treatment of Ulcerative Colitis in IBD
577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease IV: Pharmacological Management
864
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
864
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K


